Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Novartis initiates clinical trials using Emisphere's oral drug delivery technology

Sep. 9, 1999

Lexicon Genetics grants sublicense to Avatar BioSci for use of gene-trapping technology

Sep. 9, 1999

Theratechnologies and Atrix sign bone research collaboration

Sep. 9, 1999

Potent, selective human beta3-adrenoceptor antagonists discovered at Merck & Co.

Sep. 7, 1999

Celera Genomics and Gemini Research establish research collaboration

Sep. 7, 1999

SkyePharma acquires nanoparticle technology

Sep. 7, 1999

PDL granted new European patent covering humanized monoclonal antibodies

Sep. 7, 1999

3-Dimensional awarded two research grants from NIH

Sep. 6, 1999

Ligand and Parke-Davis establish research collaboration

Sep. 6, 1999

Licensing opportunity from NIH: drug delivery system for water-insoluble drugs

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...